Clinical Trials Browser

Carcinoma, Transitional Cell × toripalimab × 90 days × Clear all

NCT07314723 2026-01-02

9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer

Phase 2 Recruiting

Carcinoma, Transitional Cell